Perrigo Company has named former US Food and Drug Administration (FDA) employee Keith Webber as head of its regulatory review process.
Perrigo will benefit from Webber’s experience working with the US regulator, including most recently as acting director of the office of the FDA’s pharmaceutical science in the Center for Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs.
Prior to this, he oversaw regulation of generic medicines at the FDA as director of office of generic drug. This followed a period serving in several other leadership roles within the FDA.
The role marks a switch to the industry side of pharma for Webber, heading all the Perrigo’s regulatory activities for both its consumer healthcare and prescription medicine business.
This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.
Perrigo’s Chairman, president and CEO Joseph Papa commented that Webber “brings to us a wealth of strategic, scientific and regulatory experience from his years working with the FDA”.